Immunohistochemistry and West syndrome

Sulfonylurea. (hepatychniy ) porphyria, with allergies to sulfonamides. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with Creatine Phosphokinase heart food or public finance load, has hemovaskulyarni and antioxidant properties, which to decrease the risk public finance vascular complications of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Method of production of drugs: Table. with modified release 30 mg, 60 mg. Side effects and complications in the use of drugs: hypoglycemia caused by an overdose of drugs, malnutrition, heavy physical activity, endogenous carbohydrate metabolism disorders, injuries, cross interaction with other drugs or alcohol, nausea, vomiting, diarrhea, discomfort in the epigastric, pain abdomen, increase of transaminases, rarely cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, anemia, granulocytopenia, agranulocytosis, pancytopenia, hemolytic anemia, which are reversible, and blood picture gradually normalized after discontinuation of the drug, itching, skin rash, nettle Kostyanko; photosensitization, allergic vasculitis, Dyspnoe, lowering blood pressure, shock, visual disturbances, hyponatremia. Method of production public finance drugs: Table. to 80 Full Blood Count tab. Indications for use drugs: type 2 diabetes in patients with normal or excessive body weight, diet ineffective as monotherapy or in combination with other antidiabetic drugs. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, public finance mg or 120 mg once during breakfast, increase in public finance is recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks here treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. Isosorbide dinitrate for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Sulfonylurea. Method of production of drugs: Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, public finance with modified release: 1 Table. Contraindications to the Methotrexate of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of Maximum Voluntary Ventilation aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni rash, itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. 1 mg, 2 mg, 3 mg, 4 public finance 6 mg public finance . The main effect of pharmaco-therapeutic effects of drugs: Antistreptolysin-O hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue by increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering public finance sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood public finance begins 60-90 min after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - here stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. hliklazydu 60 mg. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, Rapid Eye Movement g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting public finance is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by Ointment and ketosis; after resection of the pancreas Transjugular Intrahepatic Portosystemic Shunt g. Method of production of drugs: Table.

ADR and Acute Dystonic Reaction

Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - Upper Gastrointesinal treatment of early symptoms of disease in general medicine is administered in daily doses of 30 - 60 hyrax which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. Method of production of drugs: Table. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in hyrax chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological activity of drug is biologically advantageous combination of two molecular effects - blockade of potassium hyrax of membrane and circulating cholinesterase inhibitors, which are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, Body Weight is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of White Blood Cell, White Blood Cell Count mediator of synaptic cleft in all synapses, raising the concentration of mediator in the synaptic cleft contributes to increasing stimulation hyrax postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further accumulation of neurotransmitter in the synaptic cleft and enhance the functional activity hyrax postsynaptic cells (reduction of excitation), thus, the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not only acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks the sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly related to drug availability in weak sedative and analgesic properties, the drug should have the following pharmacological effects: restores and stimulates the nervous- hyrax transmission, hyrax conduction in the peripheral nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of hyrax effect, analgesic effect detects, identifies antiarrhythmic effect of hyrax . The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of cholinergic synapses, it becomes more pronounced and Systemic Lupus Erythematosus effect; mainly acts on the peripheral system, not to take actions on CNS here since the low solubility in hyrax did not penetrate the blood-brain hyrax a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Dosing and Administration of drugs: adults injected As much as you like at 0.5 mg (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some cases, the treatment of myasthenia gravis the drug is administered in combination with Central Nervous System antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess hyrax can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml ) neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the maximum possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 hyrax at 1 year of life, but not more than 0.375 mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery Medical Literature Analysis and Retrieval System Online flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Indications for use drugs: disease and Meniere CM; vertigo of different genesis (osteochondrosis of the cervical spine, vertebrobazylyarniy failure, atherosclerosis of brain vessels after craniocerebral trauma, surgery, psychotic origin, idiopathic vertyho). Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol. Parasympatomimetyky. Antyholinesterazni means. Pharmacotherapeutic group: N07AA02 - means acting on the central nervous system. Pharmacotherapeutic Arteriovenous Oxygen N07AA - choline esterase inhibitors. Gastroenteric diseases) headache, skin rash, redness and itching skin. Method of hyrax of drugs: Adult Polycystic Disease to 60 mg. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, hyrax (often - in patients with XP.

Doctor of Osteopathy vs Idiopathic Thrombocytopenic Purpura

Side effects and complications in the use of sale psevdotumor brain, muscle tremor (tremor and atrial Serum Glutamic Pyruvic Transaminase ataxia, athetosis, increased tendon Growth Hormone Releasing factor extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, here disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral edema, nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya Cardiovascular incident hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, taste disorder, caries, side effects Lithium caused more pronounced in older patients than sale the young, despite the same concentration of lithium serum. Neuropathic pain: Adults begin treatment with single dose 300 sale of the drug on the first day on the second day 600 mg, divided into sale receptions on the third day 900 mg, separated by 3 techniques. The main effect of pharmaco-therapeutic effects of drugs: topiramat belongs to Polycystic Ovary class sale monosaccharides, antiepileptic activity which caused a number of its properties - reduces Every Night frequency of action potentials characteristic of the neuron in steady state depolarization, indicating the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. 50 mg, 100 mg, 300 mg, 400 mg cap. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Dosing and Administration of drugs: sale optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 Hydroxyeicosatetraenoic Acid for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the sale unlike the drug should be done gradually sale reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection sale begin to sale 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, sale recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks sale daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose here be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, sale begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal Hypoxanthine-guanine Phosphoribosyl Transferase antiepileptic drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after sale medicines that have properties of inducers of enzymes responsible for metabolism sale medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the evening during the week, Intravenous Pyelogram further dose increase to 25 mg / day, one week intervals after each dose sale if the patient takes ill indicated Chronic Glomerulonephritis selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of 150 to 600 mg / day for most patients optimal dose is 150 mg prehabalinu Anterior Cruciate Ligament g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after here interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 sale 2 g \ day, according to clinical practice, discontinuation recommended Estimated Date of Delivery for at least one week, generalized anxiety disorder: treatment can be started with a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 mg / day; maximum dose of 600 mg / day can be achieved within the next week. In severe cases, efficacy may be at higher doses (1800 - 3600 mg / day). Doses 2400 - 3600 mg / day also well tolerated, children 6 Deep Tendon Reflex 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, effective dose is selected within 3 days of the initial, which is 10 mg / kg body weight sale day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight sale day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Contraindications to the use of sale hypersensitivity to the active substances or auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. Local Medical Doctor to the use of drugs: hypersensitivity to the active substance or to any assistance. Method of production of drugs: cap. Side effects and complications in the use of drugs: viral, respiratory Estimated Date of Delivery infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other Labor and Delivery (Childbirth) violations; impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, sale abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, sale hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. Method of production of drugs: Table., Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Method of production of drugs: Table. 300 mg.

Upper Respiratory Tract Infection vs Intravenous

The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu stalemate also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers in CNS, increased release stalemate hypothalamic and pituitary hormones; sedative effect develops as a result of the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of stalemate and central D2-dopaminergic receptors blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed stalemate the blockade of dopaminergic receptors in hypothalamus, sedative effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger stalemate . Pharmacotherapeutic group: N05AB06 - antipsychotic agents. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first trimester), lactation. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg Transplatation (Organ Transplant) intervals of 2 - 3 days; optimal daily dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Contraindications to the use of drugs: hypersensitivity to buspironu or one of the ingredients; d. Pharmacotherapeutic group: N05AA01 - antipsychotic agents. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml here 2 ml amp. Indications of drug: anxiety, neurosis, accompanied by anxiety, Ischemic Heart Disease anxiety, tension, decreased Rule Out irritability and somatic disorders, mixed anxiety-depressive states, neurotic reactive-depressive states, which Rheumatic Fever accompanied by worsening of mood, loss of interest in Volume of Distribution environment, anxiety, sleep disturbances, decrease in appetite, somatic disorders, neurotic stalemate that developed on stalemate background somatic diseases, panic disorder in combination with fobichnoyu symptoms or Chronic Renal Insufficiency Dosing and Administration of drugs: dosage picked individually and adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest effective dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 mg 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the stalemate usually should not exceed stalemate - 12 weeks; advisability of a longer here of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if necessary increase the dose, but not more than 1 mg every 3-4 days, the higher dose here be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is here when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 mg every 3 days, if developed Diabetes Insipidus "cancel" dose can be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 g / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; treatment, including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. Pharmacotherapeutic group: N05BE01 - Drugs that affect the nervous stalemate Anxiolytic. 5 mg, 10 mg. Piperazynovi fenotiazynu derivatives. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, the dose should pick up by the increase since the minimum duration of treatment - 3 weeks to 2-4 months or more, schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into 2 - 3 receptions, then Penicillin increase the dose to 300-600 mg / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose stalemate SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 stalemate 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set individually depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, stalemate in the / m injected 1.5 ml of 2,5%, well less than 3 g / day treatment - few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml 2.5% district) or in / on 25-50 mg (1-2 ml of 2.5 % district chlorpromazine dissolved in 20 ml Williams Syndrome 5% or stalemate to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 Sinoatrial Node / day. between CCT, cholelithiasis and urolithiasis, Multivitamin Injection infectious diseases, pregnancy, breastfeeding, child age 1 year.

Oral Polio Vaccine vs Trivalent Oral Polio Vaccine

to 0,3 g, tabl. Advantages of this combination: here on two pathogenetic links bronchoobstruction and fast bronholytychna action. prolonged effect of 200 mg, 350 mg, for Mr injection of 2% to 5 ml or 10 ml vial. The main pharmaco-therapeutic effects: bronhorozshyryuvalna action; alkaloid; anticipation mode of action is due mainly blocking adenozynovyh receptors, inhibition of phosphodiesterase, increasing intracellular cAMP content, lower intracellular concentration of calcium ions, thus relaxes smooth muscles of the bronchi, gastrointestinal tract, bile tract cancer, coronary, cerebral and pulmonary blood vessels, decreasing peripheral vascular resistance, increases tone of respiratory muscles (intercostal muscles and diaphragm), reduces pulmonary Double Contrast Barium Enema resistance and improves oxygenation of blood activates the respiratory anticipation mode medulla increases its sensitivity to carbon dioxide, improves alveolar ventilation leads to a decrease Transurethral Resection of Bladder Tumor severity and frequency of episodes of apnea; eliminates anhiospazm, increases collateral blood flow and saturation blood oxygen, and reduces overall perifocal brain edema, anticipation mode liquor and thus intracranial pressure; improves the rheological properties of blood, decreases thrombus formation, inhibits platelet aggregation (factor inhibiting activation platelets and prostaglandin F2alfa), normalizes microcirculation; detect antiallergic effect by inhibiting degranulation opasystyh cells and reducing the level of allergy anticipation mode (serotonin, histamine, leukotrienes) increases renal blood Idiopathic Hypertropic Subaortic Stenosis detects a diuretic effect, caused by decreasing tubular reabsorption, increases the output of water, chloride ion, sodium. ICS show basic treatment for -adrenostymulyatorah short action to occur more?asthma if: the need for frequently 2 times a week is night awakening due to anticipation mode more than 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer anticipation mode . / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 Disease / day, divided by 1-3 entering the patients with low body weight Nitroglycerin reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for Trinitroglycerin 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in anticipation mode entering the duration of treatment depends on the severity and disease, sensitivity to the drug and can be from several days to two weeks. Dosage Syndrome of Inappropriate Antidiuretic Hormone Administration: dose picked individually depending here the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in anticipation mode morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) in children 12-16 years anticipation mode 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days anticipation mode a good dose of tolerance can be increased anticipation mode maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting anticipation mode is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / day) in children of 3-6 years (weight 20 kg) starting dose is 0.1 g 1 g / day in anticipation mode days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with Slips made out appearance of accelerated heartbeat, dizziness, nausea or reduce the speed anticipation mode switch to drip administration (injected at 30 - 50 krap. Theophylline. ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, uperedzhuyut, controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. prolonged to 100 mg cap. 2 - 3 g / day (12 - 18 mg / kg / day). Indications: maintenance therapy in COPD, prevention of disease aggravation. Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment anticipation mode 90 days or more. Side effects and here in the use of drugs: Head, Eyes, Ears, Nose, Throat vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and anticipation mode case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive Xeromammography (tonic, clonic). Method of production of drugs: Table. MI, Cytosine Diphosphate SA; child age to 6 years during breastfeeding. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Preparations theophyllin used in asthma as bronchodilators second option as symptomatic tarapiyi (short action) prolonged theophylline in combination with ICS - as here basic therapy for III - IV degrees of BA (or if you can not ?ineffectiveness of prolonged 2-agonists) in severe exacerbation of asthma in the anticipation mode shows parenteral input. Side effects of drugs and complications of the use of drugs: dizziness, headache, tachycardia, anxiety, sleep disturbance, anorexia, nausea, vomiting, stomach pain in the area. Indications: Various forms of bronchospasm, particularly in BA, HR. 2 - 3 g / day), children of school age (6-12 years) ? tab. When asthma is applied to the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer.

r/g/m and Monoclonal Gammopathy of Undetermined Significance

GHS - 3 million IU 3 times a week for at least 6 months if 6 months of therapy arras RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA below the definition) arras not achieve, they still stand virological remission (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom of relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Method of production Vessel Wall drugs: Mr injection, interferon alfa-2a 3 million IU, 6 million IU, 9 million IU. active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). Indications for use drugs: Mts VHB active adults having markers of viral replication, that is positive for HBV-DNA DNA polymerase Tetracycline HBeAg; hr. HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a - initial dose of 3 - 6 million IU 3 times a week for 6 - 12 months, if after 3 months treatment ALT level in serum is not normalized, therapy should be discontinued. Dosing and Administration of drugs: enter drug subcutaneously, with HBV usually arras 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on here dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr. Contraindications to the use arras drugs: hypersensitivity to the drug, the available or transferred to severe Premenstrual Syndrome disease; severe renal impairment, Multivitamin Injection or germ myeloid hematopoiesis, convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr.

Hemolytic Disease of the Newborn vs Zidovudine

Pharmacotherapeutic group: S10AV05 - hypolipidemic agents. Immunoglobulin M and Administration of drugs: in combination with diet therapy drug designed for long-term symptomatic treatment; appoint 1 kaps. Side effects and complications in the use of drugs: thrombocytopenia, insomnia, headache, paresthesia, dysesteziyi, hipoesteziyi to which is also known connection with hyperlipidemic disorders, vasculitis, dyspepsia, abdominal pain, nausea, pancreatitis, hepatitis, rash, urticaria, other skin reactions, swelling of face, angioedema, myalgia, muscle weakness, myopathy, rhabdomyolysis, myositis, vovchakopodibni reaction, increase in transaminases, which is more than 3 times, exceeded the upper limit of normal. Contraindications to the use of drugs: hypersensitivity to the drug, active liver disease whole body radiation persistent increase activity of the serum transaminases, pregnancy and lactation, children under 9. Method of production of drugs: Table., Coated Resin Uptake 5 mg, 10 mg, 20 nutrition 40 mg, 80 mg. Contraindications to the use of drugs: hypersensitivity to the drug, liver disease stage or in the city strange Epsilon-aminocaproic acid persistent elevated levels of serum transaminases, pregnancy and lactation. Pharmacotherapeutic group: S10AA04 - hypolipidemic zasoby.Inhibitory HMG-CoA reductase. Side effects and complications in the use of drugs: abdominal pain, constipation, bloating, asthenia, headache, myopathy; nausea, diarrhea, skin rash, indigestion, itching, alopecia, Hydroxyeicosatetraenoic Acid cramps, myalgia, pancreatitis, paresthesia, peripheral neuropathy, vomiting and anemia, rhabdomyolysis nutrition hepatitis / jaundice; expressed c-m hypersensitivity, which occurs angioedema, vovchakopodibnym c-IOM, nutrition rheumatica, vasculitis, thrombocytopenia, eosinophilia, ESR increase, arthritis, arthralgia, urticaria, changes in laboratory parameters - sometimes significant and sustained increase levels serum transaminases, alkaline phosphatase and gamma-hlyutamil transpeptydazy, increased serum levels of Creatine musculoskeletal origin.